Data from HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma

Abstract

<div>AbstractPurpose:<p>Glioblastoma, a common malignant intracranial tumor, has the most dismal prognosis. Autophagy was reported to act as a survival-promoting mechanism in gliomas by inducing epithelial-to-mesenchymal transition (EMT). Here, we determined the critical molecules involved in autophagy-induced EMT and elucidated the possible mechanism of chemoradiotherapy resistance and tumor recurrence.</p>Experimental Design:<p>We used isobaric tags for relative and absolute quantitation to identify the critical proteins and pathway mediating EMT via autophagy inducer treatment, and tested the expression of these proteins using tissue microarray of gliomas and clinical glioblastoma samples as well as tissues and cells separated from the core lesion and tumor-peripheral region. Analysis of the Cancer Genome Atlas database and 110 glioblastoma cases revealed the prognostic value of these molecules. The functional role of these critical molecules was further confirmed by <i>in vitro</i> experiments and intracranial xenograft in nude mice.</p>Results:<p>Autophagy inducers significantly upregulated the expression of HERC3, which promotes ubiquitination-mediated degradation of SMAD7 in an autolysosome-dependent manner. The corresponding increase in p-SMAD2/3 level and TGFβ pathway activation finally induced EMT in cell lines and primary glioblastoma cells. Moreover, HERC3 overexpression was observed in pseudo-palisade cells surrounding tumor necrosis and in tumor-adjacent tissue; high <i>HERC3</i> and low <i>SMAD7</i> levels predicted poor clinical outcome in glioblastoma; xenograft of nude mice and <i>in vitro</i> experiments confirmed these findings.</p>Conclusions:<p>Together, our findings reveal the indispensable role of HERC3 in regulating canonical SMAD2/3-dependent TGFβ pathway involvement in autophagy-induced EMT, providing insights toward a better understanding of the mechanism of resistance to temozolomide and peripheral recurrence of glioblastoma.</p></div>

HERC3 E3 ligase provides an ERAD branch eliminating select membrane proteins

“…Considering that HERC3 is primarily localized in the cytoplasm (Cruz et al, 2001), it is reasonable that HERC3 primarily acts on the misfolded CFTR dislocated to the cytoplasm. Moreover, this presumed function is in line with previous findings that HERC3 promotes the proteasomal degradation of cytosolic proteins such as RPL23A (Zhang et al, 2022b), EIF5A (Zhang et al, 2022a), and SMAD7 (Li et al, 2019). On the other hand, HERC3 appears to be at least partially involved in retrotranslocation, and its contribution may be particularly important when the function of RNF5/185 is insufficient.…”